Delivery Order SPE2DB25D3404-SPE2DB25FUQRN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $23.5K to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Viscoat syringes (0.75mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $4,853.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,172.83 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract. The order, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Viscoat Syringes (0.5 mL) under a firm fixed-price contract valued at $3,452.31. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Viscoat syringes (0.5 mL). This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract requires completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,147.21 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringes (0.5mL) with a completion date of September 4, 2025. This is a firm fixed price delivery order issued on September 3, 2025, with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQRNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 0.75 mL Viscoat syringes valued at $6,839.52 on September 24, 2025, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical and medical supply vehicle that runs through December 2026 and supports global military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability in fulfilling Defense Logistics Agency requirements across a diverse portfolio of medications, vaccines, and specialized medical devices. The company's federal contract awards with DLA reflect its competitive standing and capacity to meet federal medical supply needs through open procurement processes. This Viscoat syringe delivery order exemplifies the company's role in supplying essential medical commodities to support military healthcare operations and the broader Defense Health Agency system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/24/25 |